HHM Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

HHM Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$117K	Hold	3,460	–	–	0.01%	272
2026 Q1	$104K	Hold	3,460	–	–	0.01%	262
2025 Q4	$108K	Hold	3,460	–	–	0.01%	260
2025 Q3	$69.9K	Hold	3,460	–	–	0.01%	324
2025 Q2	$58K	Hold	3,460	–	–	0.01%	350
2025 Q1	$53.2K	Hold	3,460	–	–	0.01%	349
2024 Q4	$76.3K	Hold	3,460	–	–	0.01%	296
2024 Q3	$62.4K	Hold	3,460	–	–	0.01%	306
2024 Q2	$56.2K	Hold	3,460	–	–	0.01%	320
2024 Q1	$48.8K	Hold	3,460	–	–	0.01%	303
2023 Q4	$36.1K	Sell	3,460 -100	-3%	-$934	0.01%	333
2023 Q3	$36.3K	Hold	3,560	–	–	0.01%	320
2023 Q2	$26.8K	Hold	3,560	–	–	0.01%	380
2023 Q1	$31.5K	Hold	3,560	–	–	0.01%	341
2022 Q4	$32.5K	Hold	3,560	–	–	0.01%	296
2022 Q3	$29K	Hold	3,560	–	–	0.01%	305
2022 Q2	$27K	Hold	3,560	–	–	0.01%	379
2022 Q1	$33K	Hold	3,560	–	–	0.01%	366
2021 Q4	$29K	Hold	3,560	–	–	0.01%	379
2021 Q3	$35K	Hold	3,560	–	–	0.01%	341
2021 Q2	$35K	Hold	3,560	–	–	0.01%	337
2021 Q1	$41K	Buy	3,560 +100	+3%	+$1.15K	0.01%	306
2020 Q4	$33K	Hold	3,460	–	–	0.01%	307
2020 Q3	$31K	Hold	3,460	–	–	0.01%	274
2020 Q2	$43K	Buy	+3,460	New	+$39.1K	0.02%	242

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

HHM Wealth Advisors's TEVA Position: Q2 2026 in Review

HHM Wealth Advisors held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 3,460 shares worth $117K. The position accounts for 0.01% of the portfolio, ranked #272.

HHM Wealth Advisors first reported a position in TEVA in Q2 2020 and has held it in 25 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

HHM Wealth Advisors held 3,460 shares of Teva Pharmaceuticals worth $117K as of Q2 2026.
HHM Wealth Advisors left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up 0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #272 holding.
HHM Wealth Advisors first reported a position in Teva Pharmaceuticals in Q2 2020 and has held it in 25 quarters since.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.